ANTI-MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN 5 ANTIBODY POSITIVE

ANTI-MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN 5 ANTIBODY POSITIVE was reported 13 times

ANTI-MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN 5 ANTIBODY POSITIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SOMAPACITAN-BECO 1 0.0055
1 GONADOTROPHIN, CHORIONIC 1 0.0016
2 GOLIMUMAB 1 0.0001
3 ERGOCALCIFEROL 1 0.0000
4 NINTEDANIB 1 0.0000
5 CYCLOPHOSPHAMIDE FOR INJECTION 5 0.0000
6 CYCLOPHOSPHAMIDE 5 0.0000
7 TACROLIMUS OINTMENT 0.1% 3 0.0000
8 TACROLIMUS EXTENDED-RELEASE CAPSULES 3 0.0000
9 TACROLIMUS 3 0.0000
10 LEUPROLIDE ACETATE 1 0.0000
11 ROSUVASTATIN 1 0.0000
12 NIVOLUMAB 1 0.0000
13 LEVOTHYROXINE SODIUM ANHYDROUS 1 0.0000
14 RITUXIMAB 2 0.0000
15 MYCOPHENOLATE MOFETIL 1 0.0000
16 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 0.0000
17 METHYLPREDNISOLONE 1 0.0000
18 PREDNISOLONE ORAL SOLUTION 1 0.0000
19 PREDNISONE 2 0.0000
20 LEVOTHYROXINE SODIUM 1 0.0000
21 OMEPRAZOLE MAGNESIUM 1 0.0000
22 DUPILUMAB 1 0.0000